section name header

Indications

REMS


Unlabeled Use:
  • Acute valproic acid overdose/toxicity.

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Interactions

Drug-drug:

Availability

(Generic available)

Route/Dosage

Primary Carnitine Deficiency

Secondary Carnitine Deficiency

Carnitine Deficiency in Patients With End-Stage Renal Disease Requiring Hemodialysis.

Acute Valproic Acid Overdose/Toxicity (Off Label)

US Brand Names

Carnitor

Action

  • Carnitine is a naturally occurring metabolic compound that functions as a carrier molecule for long-chain fatty acids within the mitochondria, facilitating energy production.
Therapeutic effects:
  • Increased plasma concentrations of levocarnitine.

Classifications

Therapeutic Classification: none assigned

Pharmacokinetics

Absorption: 15% absorbed following oral administration. IV administration results in complete bioavailability.

Distribution: Unknown.

Metabolism/Excretion: Primarily metabolized in the liver to two active metabolites. Primarily excreted in the urine (76%; 4–8% as unchanged drug).

Half-Life: 17.4 hr.

Time/Action Profile

(plasma concentrations)

ROUTEONSETPEAKDURATION
POunknown3 hrunknown
IVrapidend of infusionunknown



Patient/Family Teaching

Pronunciation

lee-voe-KAR-ni-teen